Inception Growth Acquisition Ltd Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Inception Growth Acquisition Ltd quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2021 to Q2 2024.
  • Inception Growth Acquisition Ltd Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2024 was $174K, a 49.2% decline year-over-year.
  • Inception Growth Acquisition Ltd annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $732K, a 5.46% decline from 2022.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $174K -$168K -49.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $166K -$97K -36.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q2 2023 $1.76M $341K +$505K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.26M $263K +$481K Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-07-18
Q4 2022 $775K $696K Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-03
Q3 2022 $460K +$498K Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-07-18
Q2 2022 -$164K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$218K Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-07-18
Q3 2021 -$37.7K Jul 1, 2021 Sep 30, 2021 10-Q/A 2024-07-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.